ICyte Platform February 15, 2022 Unifying IntegriChain’s Services & Support: Data Management 4 Minute Read President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
Gross-to-Net February 3, 2022 Forecasting for the Future 2 Minute Read How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
Contracts & Pricing January 24, 2022 New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B 4 Minute Read Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
Corporate January 20, 2022 IntegriChain and Blue Fin Group Combine Forces 2 Minute Read Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
Launch Readiness January 19, 2022 Best Practices: Redesigning the Perfect Launch 3 Minute Read We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
Channel January 13, 2022 Frequently Asked Questions: Channel and Revenue Leakage 3 Minute Read We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
Channel December 20, 2021 Retail Pharmacy’s Digital Transformation 3 Minute Read As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
ICyte Platform November 23, 2021 A Look Back at the 2021 Access Insights Conference 2 Minute Read Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.
Contracts & Pricing November 23, 2021 Regulatory Updates 4 Minute Read This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
